219 related articles for article (PubMed ID: 21420762)
21. Synthesis and bioevaluation of hybrid 4-aminoquinoline triazines as a new class of antimalarial agents.
Kumar A; Srivastava K; Raja Kumar S; Puri SK; Chauhan PM
Bioorg Med Chem Lett; 2008 Dec; 18(24):6530-3. PubMed ID: 18951791
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and antimalarial activity of chain substituted pivaloyloxymethyl ester analogues of Fosmidomycin and FR900098.
Kurz T; Schlüter K; Kaula U; Bergmann B; Walter RD; Geffken D
Bioorg Med Chem; 2006 Aug; 14(15):5121-35. PubMed ID: 16679022
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and antimalarial activity of new haemanthamine-type derivatives.
Cedrón JC; Gutiérrez D; Flores N; Ravelo ÁG; Estévez-Braun A
Bioorg Med Chem; 2012 Sep; 20(18):5464-72. PubMed ID: 22910226
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of oxalamide and triazine derivatives as a novel class of hybrid 4-aminoquinoline with potent antiplasmodial activity.
Sunduru N; Sharma M; Srivastava K; Rajakumar S; Puri SK; Saxena JK; Chauhan PM
Bioorg Med Chem; 2009 Sep; 17(17):6451-62. PubMed ID: 19665899
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of solution-phase combinatorial library of 4,6-diamino-1,2-dihydro-1,3,5-triazine and identification of new leads against A16V+S108T mutant dihydrofolate reductase of Plasmodium falciparum.
Vilaivan T; Saesaengseerung N; Jarprung D; Kamchonwongpaisan S; Sirawaraporn W; Yuthavong Y
Bioorg Med Chem; 2003 Jan; 11(2):217-24. PubMed ID: 12470716
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and structure-activity relationships of 4-pyridones as potential antimalarials.
Yeates CL; Batchelor JF; Capon EC; Cheesman NJ; Fry M; Hudson AT; Pudney M; Trimming H; Woolven J; Bueno JM; Chicharro J; Fernández E; Fiandor JM; Gargallo-Viola D; Gómez de las Heras F; Herreros E; León ML
J Med Chem; 2008 May; 51(9):2845-52. PubMed ID: 18396855
[TBL] [Abstract][Full Text] [Related]
27. New ferrocenic pyrrolo[1,2-a]quinoxaline derivatives: synthesis, and in vitro antimalarial activity--Part II.
Guillon J; Mouray E; Moreau S; Mullié C; Forfar I; Desplat V; Belisle-Fabre S; Pinaud N; Ravanello F; Le-Naour A; Léger JM; Gosmann G; Jarry C; Déléris G; Sonnet P; Grellier P
Eur J Med Chem; 2011 Jun; 46(6):2310-26. PubMed ID: 21458112
[TBL] [Abstract][Full Text] [Related]
28. 1-Aryl-4,6-diamino-1,2-dihydrotriazine as antimalarial agent: a new synthetic route.
Kidwai M; Mothsra P; Mohan R; Biswas S
Bioorg Med Chem Lett; 2005 Feb; 15(4):915-7. PubMed ID: 15686886
[TBL] [Abstract][Full Text] [Related]
29. 1H-1,2,3-triazole tethered mono- and bis-ferrocenylchalcone-β-lactam conjugates: synthesis and antimalarial evaluation.
Kumar K; Pradines B; Madamet M; Amalvict R; Kumar V
Eur J Med Chem; 2014 Oct; 86():113-21. PubMed ID: 25147153
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, Docking, In Vitro and In Vivo Antimalarial Activity of Hybrid 4-aminoquinoline-1,3,5-triazine Derivatives Against Wild and Mutant Malaria Parasites.
Bhat HR; Singh UP; Gahtori P; Ghosh SK; Gogoi K; Prakash A; Singh RK
Chem Biol Drug Des; 2015 Sep; 86(3):265-71. PubMed ID: 25487527
[TBL] [Abstract][Full Text] [Related]
31. New chimeric antimalarials with 4-aminoquinoline moiety linked to a tetraoxane skeleton.
Opsenica I; Opsenica D; Lanteri CA; Anova L; Milhous WK; Smith KS; Solaja BA
J Med Chem; 2008 Oct; 51(19):6216-9. PubMed ID: 18774792
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and antimalarial activities of some furoxan sulfones and related furazans.
Galli U; Lazzarato L; Bertinaria M; Sorba G; Gasco A; Parapini S; Taramelli D
Eur J Med Chem; 2005 Dec; 40(12):1335-40. PubMed ID: 15979766
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of 4-pyrido-6-aryl-2-substituted amino pyrimidines as a new class of antimalarial agents.
Agarwal A; Srivastava K; Puri SK; Chauhan PM
Bioorg Med Chem; 2005 Nov; 13(22):6226-32. PubMed ID: 16054819
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, Plasmodium falciparum Inhibitory Activity, Cytotoxicity and Solubility of N2 ,N4 -Disubstituted Quinazoline-2,4-diamines.
Pobsuk N; Suphakun P; Hannongbua S; Nantasenamat C; Choowongkomon K; Gleeson MP
Med Chem; 2019; 15(6):693-704. PubMed ID: 30569870
[TBL] [Abstract][Full Text] [Related]
35. Pharmacophore based discovery of potential antimalarial agent targeting haem detoxification pathway.
Acharya BN; Saraswat D; Kaushik MP
Eur J Med Chem; 2008 Dec; 43(12):2840-52. PubMed ID: 18395298
[TBL] [Abstract][Full Text] [Related]
36. Application of multi-component reactions to antimalarial drug discovery. Part 1: Parallel synthesis and antiplasmodial activity of new 4-aminoquinoline Ugi adducts.
Musonda CC; Taylor D; Lehman J; Gut J; Rosenthal PJ; Chibale K
Bioorg Med Chem Lett; 2004 Aug; 14(15):3901-5. PubMed ID: 15225694
[TBL] [Abstract][Full Text] [Related]
37. Search for new pharmacophore as antimalarial agent: synthesis and antimalarial activity of some 2(3H)-furanones bearing quinoline moiety.
Alam MM; Sarkar DP; Alam O; Husain A; Marella A; Akhtar M; Shaquiquzzaman M; Khanna S
Acta Pol Pharm; 2011; 68(2):231-6. PubMed ID: 21485296
[TBL] [Abstract][Full Text] [Related]
38. Antimalarial and antiplasmodial activities of norneolignans. Syntheses and SAR.
Skytte DM; Nielsen SF; Chen M; Zhai L; Olsen CE; Christensen SB
J Med Chem; 2006 Jan; 49(1):436-40. PubMed ID: 16392829
[TBL] [Abstract][Full Text] [Related]
39. Exploration of a new type of antimalarial compounds based on febrifugine.
Kikuchi H; Yamamoto K; Horoiwa S; Hirai S; Kasahara R; Hariguchi N; Matsumoto M; Oshima Y
J Med Chem; 2006 Jul; 49(15):4698-706. PubMed ID: 16854076
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis, and application of novel triclosan prodrugs as potential antimalarial and antibacterial agents.
Mishra S; Karmodiya K; Parasuraman P; Surolia A; Surolia N
Bioorg Med Chem; 2008 May; 16(10):5536-46. PubMed ID: 18434169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
